XML 16 R5.htm IDEA: XBRL DOCUMENT v3.24.2.u1
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Jun. 30, 2024
Dec. 31, 2023
Current assets:    
Cash and cash equivalents $ 28,847 $ 31,167
Marketable securities 42,535 73,944
Accounts receivable, net 33,377 12,103
Inventories 13,313 10,380
Research and development tax credit receivable 927 1,322
Prepaid expenses and other current assets 6,781 5,286
Total current assets 125,780 134,202
Property and equipment, net 484 585
Operating lease right-of-use assets 2,154 2,591
Goodwill 16,836 16,836
Research and development tax credit receivable 252 332
Other non-current assets 12,015 10,152
Total assets 157,521 164,698
Current liabilities:    
Current portion of operating lease liability 866 934
Accounts payable 9,794 11,433
Accrued expenses 33,711 24,227
Other current liabilities 242 261
Total current liabilities 44,613 36,855
Long-term operating lease liability 1,308 1,690
Royalty financing obligation 35,493 32,760
Other non-current liabilities 5,819 5,654
Total liabilities 87,233 76,959
Shareholders’ equity:    
Preferred shares, nominal value of $0.01 per share; 50,000 shares authorized; zero issued and outstanding at June 30, 2024 and 5,194 issued and outstanding at December 31, 2023 0 52
Ordinary shares, nominal value of $0.01 per share; 500,000 shares authorized; 96,204 issued and outstanding at June 30, 2024 and 89,825 issued and outstanding at December 31, 2023 961 898
Additional paid-in capital 880,202 855,452
Accumulated deficit (786,660) (745,496)
Accumulated other comprehensive loss (24,215) (23,167)
Total shareholders’ equity 70,288 87,739
Total liabilities and shareholders’ equity $ 157,521 $ 164,698